Patrick Greatrex has been appointed the new CEO of Medtech company Vivo Line Medical, taking office March 9. He succeeds Peter Sebelius.
Previously Greatrex was CEO of CMC Contrast, CEO of Combigene and vice president of Glycorex Transplantation. He also worked on business development for Gambro.
Peter Sebelius did not leave the company, but is continuing to serve as chief operating officer (COO.)
“I definitely want to help and make sure that all the exciting projects that I started will continue,” Sibelius says to news agency Directly.
Source: Life Science Sweden